Quebec City, QC
Atrium Biotechnologies develops and commercializes innovative cosmetic and nutritional ingredients by establishing research and distribution partnerships. Atrium Biotechnologies, subsidiary, of terna Laboratories, was created officially in January 2000 in order to answer our customers needs for high value innovative ingredients in the cosmetic and nutritional fields.
1405, boul. du Parc-Technologique
Quebec City, QC G1P 4P5
CA
1405, boul. du Parc-Technologique
Quebec City, QC G1P 4P5
CA
Legal Name: Atrium Biotechnologies Inc.
Number of Employees: 28
CA
Advanced technology such as the extraction by ultra-filtration is the origin of most of Atriums products. The available technologies allow us to isolate different complexes or specific molecules starting from the biomass. Such production or purification procedures allow us to develop ingredients that provide the awaited benefits while diminishing the risks of undesirable secondary effects.
Title: Vice President
Area of Responsibility: Research/Development/Engineering
Phone: Show phone
Fax: Show fax
Email: Show email
Title: Prsident Chef da la Direction
Area of Responsibility: Management Executive
Phone: Show phone
Fax: Show fax
Email: Show email
Title: Vice President
Area of Responsibility: Export Sales & Marketing
Phone: Show phone
Title: Director
Area of Responsibility: Management Executive
Phone: Show phone
Fax: Show fax
Email: Show email
Nutritional supplements: NaTCell, CarTcell, Skin care products: PRE & MDI Complexes, Dermanex, Tensea, Marine Biopolymer, Tensea
541710
Brazil, France, Hong Kong, Indonesia, Italy, Japan, Korea, North, Korea, South, Portugal, Russian Federation, Spain, United Kingdom, United States
Argentina, Chile, China, Germany, Greece, Taiwan